Health Care/Hospital
Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
SHANGHAI and HONG KONG, March 26, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hem...
Gene Solutions Leads the Way in Cancer Early Detection with Asia's First Clinical Validated Multi-Cancer Blood Test
SINGAPORE, March 26, 2025 /PRNewswire/ -- Gene Solutions
Singapore's Best Workplaces in Healthcare & Biopharma™ 2025 Announced, Showcasing Insights from Nearly 10,000 Employees
SINGAPORE, March 26, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has officially announcedSingapore's Best Workplaces in Healthcare & Biopharma™ 2025 list, celebrating 10 pioneering healthcare and biopharma companies that have created exceptional workplace...
Alphamab Oncology Reports Full Year 2024 Financial Results and Business Highlights
SUZHOU, China, March 26, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year endedDecember 31, 2024 and highlighted recent business progress. Financial Summary * For the year ended December 31, 2024, we recorded total revenue of RMB 640.08...
Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes
JINAN, China, March 26, 2025 /PRNewswire/ -- Recently, Professor Sun Jinpeng's team atShandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis" in Science. This study employed high-throughp...
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
SHANGHAI, March 26, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial results for ...
Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly TBM-00...
Alma introduces Alma Harmony, a state-of-the-art aesthetic platform for next-level in-office treatments
Featuring a simply intelligence interface and substantial technological
upgrades, the new multiplatform presents a new era in patient personalization
CAESAREA, Israel, March 26, 2025 /PRNewswire/ -- Alma Lasers
Kolmar Korea Develops World's First Hybrid Composite Sunscreen, Leading the Global Suncare Market
SEOUL, South Korea, March 25, 2025 /PRNewswire/ -- Global Cosmetics ODM (Original Development Manufacturer) Kolmar Korea has achieved a groundbreaking milestone by developing the world's first hybrid composite sunscreen stabilization technology. This innovation seamlessly integrates the great UV ...
Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines
MANILA, Philippines, March 25, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation, Inc. (HFI) and the Municipality of Malinao to launch a comprehensive initiative to improve nutrition ...
3Shape Unveils Revolutionary TRIOS 6 Intraoral Scanner and TRIOS Dx Plus Diagnostic Software at IDS
COPENHAGEN, Denmark, March 25, 2025 /PRNewswire/ -- 3Shape today proudly introduces its revolutionary TRIOS 6 intraoral scanner, Diagnostic software - TRIOS Dx Plus*, and the DentalHealth patient app. The new TRIOS 6 intraoral scanner not only incorporates several new upgrades, including hypersp...
Rare loss-of-function variants in HECTD2 and AKAP11 confer a risk of bipolar disorder
Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. REYKJAVIK, Iceland, March 25, 2025 /PRNewswire/ -- Bipolar disorder is characterized by extreme mood swings, bouts of mania...
meerecompany enhances Korea-Vietnam medical exchange with Revo-i fellowship program
- Launch of SSC program to provide advanced robotic surgery training in Korea - Dr. Cao from Viet Tiep Friendship Hospital in Vietnam completed training at Severance Hospital SEOUL, South Korea, March 25, 2025 /PRNewswire/ -- meerecompany (CEO: Joon Koo Kim) announced today that its Revo-i surgi...
Exceptional Performance for Ureteral Stents: ICP DAS-BMP Reveals Latest TPU Materials at CMEF 2025
HSINCHU, March 25, 2025 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a committedTaiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is excited to announce its participation in CMEF (China International Medical Equipment Fair), held fromApril 8-11, 2025,...
Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY
SHANGHAI, March 24, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximatelyRMB5.7244 billion, representing an increase of 6.1% YoY. The net profit reachedRMB820.5 million, a 50.3% YoY growth, with a net pr...
Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY
SHANGHAI, March 24, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximatelyRMB5.7244 billion, representing an increase of 6.1% YoY. The net profit reachedRMB820.5 million, a 50.3% YoY growth, with a net pr...
Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120
Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announc...
NX Taiwan Receives Occupational Health and Safety Management System Certification
- Maintaining Safe, Healthy and Competitive Work Environment Top Priority - TOKYO, March 24, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd. (hereafter "NX Taiwan"), a group company of NIPPON EXPRESS HOLDINGS, INC., acquired ISO 45001:2018 certification for its occupational health and safe...
English Version of "Long-term Care Tech Portal" Newly Launched, Introducing Latest Care and Age Tech in Japan
TOKYO, March 24, 2025 /PRNewswire/ -- The long-term care robot portal site
management office released the English version of the "Long-term Care Tech
Portal" (https://robotcare.jp/en/home/index?type=pw
GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
* Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib * Nearly all myelofibrosis patients globally are estimated to develop anaemia over the course of the disease, and over 30% will discontinue treatment due to ...
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 284 media titles]
2026-06-08 09:00